Algernon Health Inc. Boosts Neuro‑Disease Portfolio with Successful NMDA Hunter Launch
Algernon Health Inc. pushes neuro‑degenerative breakthroughs, boasting NMDA HUNTER’s U.S./Canada launch for Huntington’s and future Alzheimer’s, Parkinson’s plans.
3 minutes to read